
    
      To compare the clinical impact of Acthar Gel at the cellular and molecular level before and
      after treatment and compare it to patients with inactive disease. The cohort of active
      myositis subjects are not actually enrolled in this study, but rather the data for those with
      active myositis will be obtained from a previously completed trial entitled "Efficacy and
      safety of Adenocorticotropic Hormone Gel in Refractory dermatomyositis and polymyositis".
    
  